conference abstract
-
[Abstract] S331: Results of a Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Bezisterim (NE3107) in LC (ADDRESS-LC),2026,Markham
Abstract Background: Long COVID continues to burden a significant percentage of the population with debilitating symp-toms, including cognitive impairment ("brain fog"), fatigue, post-exertional malaise (PEM), and sleep disturbance, contributing to a poor quality of life (QoL). Evidence...- Chandelier
- Thread
- address-lc bezisterim biovie conference abstract long covid
- Replies: 4
- Forum: Long Covid research
-
E
Fatigue in post COVID-19 patients: the P4O2 COVID-19 study, 2023, Maitland-Van der Zee et al
Fatigue in post COVID-19 patients: the P4O2 COVID-19 study Abstract Background: Some patients do not fully recover after COVID-19 and have symptoms occurring 3 months after acute illness, lasting for >2 months, defined as post COVID-19. Fatigue seems most present in post COVID-19 and part of...- EndME
- Thread
- conference abstract
- Replies: 5
- Forum: Long Covid research